Matthew Miller, associate professor, biochemistry and biomedical sciences, explains the UK variant of COVID-19 and the effectiveness of vaccines against other mutations of the virus.
February 1, 2021
Professor
Matthew Miller, associate professor, biochemistry and biomedical sciences in the Faculty of Health Sciences, explains the UK variant of COVID-19 and the effectiveness of vaccines against other mutations of the virus.
“The good news is, existing vaccines appear to work just as well against this variant as they do against the prior dominant form of SARS-CoV-2.”
This research, and research like it, is part of Canada’s Global Nexus for Pandemics and Biological Threats, an international network launched at McMaster with scientists, clinical health and medical specialists, engineers, social scientists and other experts working collaboratively to prevent future pandemics and mitigate global health threats.